1 month Northland Securities Begins Coverage on TriSalus Life Sciences (NASDAQ:TLSI)MarketBeat
Northland Securities started coverage on TriSalus Life Sciences in a research report on Friday. They set an “outperform” rating and a $12.50 target price for the company.
X